Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 5.574% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CN(CC(CC(=O)Nc1nncs1)c1ccccc1)S(=O)(=O)c1ccccc1
(b) Cc1cc(C)n(CCC(=O)N/N=C/c2ccccc2O)n1
(c) O=C(COc1ccc(F)cc1Cl)N(Cc1nnc(-c2ccccc2Cl)o1)C1CC1
Answer: b. Cc1cc(C)n(CCC(=O)N/N=C/c2ccccc2O)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)n(CCC(=O)N/N=C/c2ccccc2O)n1
Cc1cc(C)n(CCC(=O)N/N=C/c2ccccc2O)n1
3-(3,5-dimethylpyrazol-1-yl)-N-[(E)-(2-hydroxyphenyl)methylideneamino]propanamide